Immunologynpj VaccinesPeer-reviewed
A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responses
Veronica P. Zoest, Wen Shi Lee, Lydia Murdiyarso…·Hyon‐Xhi Tan
A chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and HKU-1 scaffold domains elicits potent neutralising antibodies and CD4 T cell help in mice and macaques.
2 citations